Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal buprenorphine patch in physically opioid-dependent cancer patients
KCT0005159Phase 2Completed
- Sponsor
- BC World Pharm
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine in cancer pain, opioid use disorder (OUD), sponsored by BC World Pharm. Started Aug 2020; status: completed.
02
Drugs
buprenorphine
03
Conditions
cancer painopioid use disorder (OUD)
Beyond the preview
Go deeper on KCT0005159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005159.